Robinswood Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.5K Sell
100
-25
-20% -$8.56K 0.01% 177
2026
Q1
$44.2K Hold
125
0.01% 149
2025
Q4
$41K Hold
125
0.01% 157
2025
Q3
$35.3K Hold
125
0.01% 163
2025
Q2
$34.9K Hold
125
0.01% 167
2025
Q1
$38.9K Hold
125
0.01% 149
2024
Q4
$32.6K Hold
125
0.01% 144
2024
Q3
$40.3K Hold
125
0.02% 141
2024
Q2
$39.1K Hold
125
0.02% 139
2024
Q1
$35.4K Hold
125
0.02% 109
2023
Q4
$36K Hold
125
0.02% 99
2023
Q3
$33.6K Hold
125
0.02% 100
2023
Q2
$27.8K Buy
+125
New +$29K 0.01% 98

Other funds holding AMGN

Robinswood Financial's AMGN Position: Q2 2026 in Review

Robinswood Financial reduced its Amgen (AMGN) stake by 20% in Q2 2026, selling an estimated $8.56K and leaving 100 shares worth $36.5K. The position accounts for 0.01% of the portfolio, ranked #177.

Robinswood Financial first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $44.2K in Q1 2026. 937 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Robinswood Financial held 100 shares of Amgen worth $36.5K as of Q2 2026.
  • Robinswood Financial sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.01% of Robinswood Financial's portfolio in Q2 2026, its #177 holding.
  • Robinswood Financial first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Robinswood Financial's Amgen position peaked at $44.2K in Q1 2026.
  • 937 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Robinswood Financial's 13F filing for Q2 2026, filed 15 Jul 2026.